{"filing":{"accession_number":"0001906324-26-000036","cik":"0001906324","ticker":"QDEL","company_name":"QuidelOrtho Corp","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-23","primary_document":"qdel-20260923.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1906324/000190632426000036/qdel-20260923.htm"},"events":[{"id":34638,"run_id":31879,"accession_number":"0001906324-26-000036","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"QuidelOrtho entered into Amendment No. 1 to its existing credit agreement on September 23, 2026, which materially modifies the terms of its $3.3 billion financing package (Term Loan A Facilities, Term Loan B, and Revolving Credit Facility). While technically an amendment rather than a new issuance, the amendment resets financial covenant levels through September 2029, adjusts interest rates and commitment fees, and adds additional restrictions to financial covenants—all material modifications to the company's direct financial obligations. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and would materially affect a reasonable investor's assessment of the company's debt structure and financial flexibility.","company_name":"QuidelOrtho Corp","ticker":"QDEL","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38431,"accession_number":"0001906324-26-000036","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"QuidelOrtho entered into Amendment No. 1 to its existing credit agreement on September 23, 2026, which materially modifies the terms of its $3.3 billion financing package (Term Loan A Facilities, Term Loan B, and Revolving Credit Facility). While technically an amendment rather than a new issuance, the amendment resets financial covenant levels through September 2029, adjusts interest rates and commitment fees, and adds additional restrictions to financial covenants—all material modifications to the company's direct financial obligations. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and would materially affect a reasonable investor's assessment of the company's debt structure and financial flexibility.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T20:43:00.838501+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38431,"accession_number":"0001906324-26-000036","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"QuidelOrtho entered into Amendment No. 1 to its existing credit agreement on September 23, 2026, which materially modifies the terms of its $3.3 billion financing package (Term Loan A Facilities, Term Loan B, and Revolving Credit Facility). While technically an amendment rather than a new issuance, the amendment resets financial covenant levels through September 2029, adjusts interest rates and commitment fees, and adds additional restrictions to financial covenants—all material modifications to the company's direct financial obligations. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and would materially affect a reasonable investor's assessment of the company's debt structure and financial flexibility.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T20:43:00.838501+00:00","company_name":"QuidelOrtho Corp","ticker":"QDEL","filing_date":"2026-09-23"}]}